N1’s dual-engine (peptide and polymer) powered technology platform is combined with its proprietary data-driven transporter discovery. Molecular transporters enable drug molecules of different sizes and properties to overcome biological barriers and drug resistance. The company has established its fast-growing and sustainable model that utilizes the platform’s great and widely applicable potential for both its in-house pipelines and co-development partnerships. N1 Life’s R&D program covers areas from oncology to dermatology, ophthalmology, neurological diseases, and infectious diseases.

N1 Life has an extended pipeline of co-development partnerships aimed at growing the usage of our technology platforms. We use these technology platforms to expand the applications of drugs, make drug development more effective and productive, and give more options to people facing serious health challenges.